*Cincinnati Eye Institute, Cincinnati, OH;
†Department of Ophthalmology, University of Cincinnati College of Medicine, Cincinnati, OH;
‡Virginia Eye Consultants, Norfolk, VA;
§Ospedale Oftalmico di Torino, Struttura Complessa Oculistica 2, Turin, Italy; and
¶Division of Nephrology and Hypertension, University of Cincinnati, Cincinnati, OH.
Correspondence: Edward J. Holland, MD, Cincinnati Eye Institute, 580 South Loop Rd, Suite 200, Edgewood, KY 41017 (e-mail: [email protected]).
E. J. Holland has consulted for Alcon Laboratories, Allergan, Bausch & Lomb, Kala Pharmaceuticals, Mati Pharmaceuticals, Omeros, Senju Pharmaceuticals, Shire, and TearLab. A. Y. Cheung had a Grant from the Eye Bank Association of America and has consulted for Alcon. The remaining authors have no conflicts of interest to disclose.
